GCTK

0.18331.98%
DC

David C. Klonoff

Chair of Scientific Advisory Board

Dr. David C. Klonoff, FACP, M.D. is Clinical Advisory Board of Glooko, Inc. Fellow AIMBE is Member of Clinical Advisory Board of Afon Technology Limited. He was Member of Clinical Advisory Board at Proteomics International Laboratories Limited since April 2022. He serves as Member of Scientific Advisory Board at Rockley Photonics Holdings Limited since August 2022. He serves as Member of Clinical Advisory Board at Atropos Health, Inc. since March 2023. He is a Clinical Professor of Medicine at the University of California at San Francisco and an endocrinologist specialising in bioengineered solutions for people with diabetes. In 2001, he established the Diabetes Technology Society to accelerate positive changes in diabetes care. He is an endocrinologist specializing in the development and use of diabetes technology. He serves as the Chairman of Scientific Advisory Board at GlucoTrack, Inc. (formerly known as Integrity Applications, Inc.) since April 2021. has led many multi-stakeholder technical and clinical standards projects including for continuous glucose monitor data (Clinical Laboratory Standards Institute), hospital guidelines for using continuous glucose monitors and automated insulin dosing systems (Diabetes Technology Society) and cybersecurity for wireless diabetes devices (IEEE). He is co-chair of the iCoDE standard project to integrate continuous glucose monitor data into the electronic health record. He is the only person in the world to be an advisor or investigator for all four manufacturers of the first four non-invasive glucose monitors to receive a CE Mark. He served as Chairman of Scientific Advisory Board at Lifecare AS until October 2024. Dr. Klonoff served as Member of Medical, Scientific & Regulatory Advisory Board at Know Labs, Inc since April 2019. Dr. Klonoff is a Clinical Professor of Medicine at UCSF and the Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, California. Dr. Klonoff served as Medical Advisor at C8 MediSensors, Inc. Dr. Klonoff is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology. Dr. Klonoff is an endocrinologist specializing in diabetes. Dr. Klonoff chaired the scientific advisory board for development of the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first three FDA-approved incretin drugs for diabetes and many other devices and drugs. Dr. Klonoff founded: the Diabetes Technology Meeting (the second largest scientific diabetes meeting in the US); the Clinical Diabetes Technology Meeting; and the International Hospital Diabetes Meeting. Dr. Klonoff chaired the Endocrine Society Task Force on CGM Clinical Guidelines and the CLSI Subcommittee on CGM Metrics (POCT5). Dr. Klonoff serves as Member of the Scientific Advisory Board at Medingo Ltd. He served as Member of Scientific Advisory board at MannKind Corp. He was a member of the NIH Diabetes Interagency Coordinating Committee Subgroups on Bioengineering Technologies and Resources & Infrastructure whose ten-year research plan was released in 2011 and the JDRF Clinical Recommendations Panel on Closed Loop Systems. Dr. Klonoff received an FDA Director' Special Citation Award in 2010 for outstanding contribution related to diabetes technology and the American Diabetes Associations 2019 Outstanding Physician Clinician Award in 2019. He was named best endocrinologist in San Mateo County by Bay Area Consumer Checkbook. He has authored 140 publications. Dr. Klonoff has chaired or served on grant review panels for NIH, CDC, NASA, National Science Foundation, US Army and JDRF. He has served as a Civilian Medical Officer for the US Army Telemedicine and Advanced Technology Research Center in the areas of biosensors and physiologic monitoring. Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals. Dr. Klonoff served as Member of the Scientific Advisory Board at Medingo Ltd. and MannKind Corp. He served as a Member of Scientific Advisory Board at InsuLine Medical Ltd.

Positions